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Background:  The second Medical, Angioplasty, or Surgery Study (MASS II) compared the long-term effects of medical treatment (MT), angioplasty 
(PCI), or surgical strategies (CABG) among patients with stable angina symptoms of multivessel coronary artery disease (CAD) and preserved 
ventricular function who were appropriate candidates for all 3 therapies. Plasma lipids are important risk factors for cardiovascular events in 
CAD patients. In this analysis we evaluated the association of plasma lipids as well as risk factors and randomized therapy for CAD with major 
cardiovascular events (MACE, overall death, myocardial infarction, and unstable angina that required myocardial revascularization) after a 10-year 
follow-up of the MASS II.
Methods:  611 patients were randomly assigned to CABG (n=203), PCI (n=205), or MT (n=203). Fasting plasma lipids were determined at baseline 
and 6 months after randomization. Lipid modifying therapies were equally instituted in all study patient groups. Concentrations of total cholesterol, 
HDL, non-HDL and LDL-cholesterol as well as LDL/HDL, and TG/HDL ratios were divided according to distribution quartiles. The association of 
plasma lipids at baseline and at 6 months, as well as other risk factors and randomized CAD treatment with MACE occurrance was determined by 
Cox regression models.
Results:  All alive patients were followed up for an average of 11.4 years (varying from 9 to 15). MACE occurred respectively in 42.4%, 59.1%, and 
33.0% of those randomized respectively to PCI, MT and CABG. After adjustment for confounders, older age (> 65 years old, p<0.001), randomized 
treatment for CAD (CABG vs. MT, p<0.0001), systemic arterial hypertension (p=0.016), and the TG/HDL ratio determined at 6 months (p=0.012) 
were independently associated with MACE. The hazard ratio for the occurrence of MACE comparing the highest and lowest quartile of the TG/HDL 
ratios was 1.57 (95% CI 1.09-2.26), p=0.015. No association was found between MACE and other plasma lipids.
Conclusions:  The TG/HDL was the only lipid parameter independently associated with MACE after the 10-year follow up of stable CAD patients in 
the MASS II.
